HomeNVCT • NASDAQ
add
Nuvectis Pharma Inc
Previous close
$7.15
Day range
$6.97 - $7.28
Year range
$4.44 - $12.10
Market cap
139.88M USD
Avg Volume
114.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.36M | -29.21% |
Net income | -4.15M | 29.38% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.17M | -22.17% |
Total assets | 17.31M | -22.26% |
Total liabilities | 6.32M | 13.27% |
Total equity | 10.99M | — |
Shares outstanding | 19.32M | — |
Price to book | 12.33 | — |
Return on assets | -61.21% | — |
Return on capital | -92.67% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.15M | 29.38% |
Cash from operations | -2.40M | 25.89% |
Cash from investing | — | — |
Cash from financing | 1.46M | 107.25% |
Net change in cash | -947.00K | 62.73% |
Free cash flow | -1.03M | 37.07% |
About
Founded
2020
Headquarters
Website
Employees
13
